Wellgistics Health's 200% Increase Highlights AI-Pharma Partnerships in ETFs
Wellgistics Health Inc Surge: Wellgistics Health Inc (WGRX) saw its stock price soar over 200% following a collaboration announcement with Datavault AI Inc (DVLT) to integrate blockchain technology into pharmaceutical logistics, attracting significant attention from investors and ETFs focused on AI and healthcare.
Convergence of Technologies: The partnership aligns with a growing trend of merging AI, blockchain, and healthcare innovation, with thematic ETFs like ARK Genomic Revolution ETF and ROBO Global Healthcare Technology and Innovation ETF already capitalizing on this convergence.
PharmacyChain Platform: The collaboration aims to develop the PharmacyChain platform, which will enhance transparency in drug tracking and address longstanding issues in pharmacy logistics, while also exploring a revenue-sharing model for platform usage.
Technological Advancements: This initiative follows Wellgistics' launch of HubRx AI, its proprietary AI platform for pharmacy operations, indicating a strong commitment to leveraging technology for improved efficiency in the healthcare supply chain.
Trade with 70% Backtested Accuracy
Analyst Views on DVLT
About DVLT
About the author

- First Profit Milestone: Datavault AI achieved its first profitable quarter on a GAAP basis in Q4 2025, with adjusted EBITDA exceeding $8 million, marking a significant improvement in financial health that is likely to attract increased investor interest.
- Strategic Acquisitions and Project Launch: The company acquired CompuSystems and API Media while launching the Event Citadel project, which integrates event data and audience engagement for monetization across digital and physical environments, further enhancing its competitive edge in the market.
- Blockchain and Data Monetization: Management emphasized the integration of blockchain and Web 3 ecosystems, positioning Datavault AI to enter scalable recurring revenue models, which is expected to drive long-term revenue growth potential for the company.
- International Expansion and Compliance: The company reiterated its $200 million revenue target for 2026, highlighting the growth potential in international markets while ensuring compliance in new regions to support future expansion plans.
- Profit Turnaround: Datavault achieved an operating profit of $4.2 million in Q4 2025, reversing a $6.3 million loss from the previous year, indicating a significant improvement in the company's financial health.
- Revenue Surge: Fiscal 2025 revenue soared to $39.1 million, marking a staggering 1,362% year-on-year increase, reflecting strong demand for its intellectual property licensing and tokenization solutions, although Q4 revenue of $33.8 million fell short of guidance.
- Strategic Acquisitions: The company strengthened its platform through acquisitions of CompuSystems and API Media Innovations, currently holding approximately $116 million in working capital and $142.9 million in current assets, with no long-term debt, enhancing financial stability.
- Future Outlook: Datavault reiterated its 2026 revenue target of $200 million, projecting nearly a 400% year-on-year increase, demonstrating confidence in future growth despite a more than 17% drop in stock price on Thursday morning.
- Financial Highlights: Datavault AI's earnings report reveals a GAAP EPS of -$0.52, yet revenue surged to $39.09 million, reflecting a staggering 1364% year-over-year increase, indicating robust growth potential in the market.
- Revenue Guidance Reaffirmed: The company reiterates its FY26 revenue target of $200 million, representing nearly a 400% increase from FY25, which, if achieved, will further solidify its leadership position in the industry.
- Market Reaction Analysis: Despite the impressive revenue growth, the market's reaction to the EPS loss may lead to short-term stock price volatility, prompting investors to monitor future profitability improvements closely.
- Strategic Partnership: Datavault AI's collaboration with Riflessi to launch holographic retail displays aims to enhance customer experience through innovative technology, thereby driving sales growth and strengthening competitive positioning in the market.
- Surge in Technology Demand: Datavault AI, specializing in data monetization and real-world asset tokenization, has seen a significant increase in demand for its technology solutions, with projected fiscal year 2025 revenues ranging from $38 million to $40 million, substantially exceeding the previous forecast of $30 million, indicating strong market demand and client trust.
- Strategic Investment Support: In 2025, Datavault AI secured a $150 million strategic investment from Scilex Holding Company, providing additional resources to support ongoing expansion and operational scaling, thereby enhancing its competitive position in the market.
- Asset Managers Increasing Holdings: Between Q4 2025 and February 2026, major asset managers dramatically increased their stakes in Datavault AI, with Vanguard boosting its holdings from approximately 393,000 shares to 11.8 million shares, State Street rising from about 335,000 shares to 10 million shares, and BlackRock expanding from 136,000 shares to 4.1 million shares, reflecting strong institutional confidence in the company.
- Strong Stock Performance: As of 2026, DVLT stock has gained over 19% year-to-date and surged over 14% in Wednesday's premarket trading, reflecting retail investor optimism ahead of the upcoming Q4 and full-year 2025 earnings report, with market sentiment shifting from 'bearish' to 'bullish'.

Complaint Filed: A complaint has been filed against CILEX Holding Co. alleging unauthorized sale of pledged DVLTS shares.
Involvement of SEC: The complaint has been submitted to the SEC, indicating regulatory scrutiny over the transaction.
- Lawsuit Background: Scilex Holding Company has filed a lawsuit in the Central District of California against Marc Wade and St. James Bank, alleging unauthorized transfer of approximately 96 million shares of Datavault stock, with losses exceeding $100 million, highlighting significant risks in the company's equity management.
- Pledged Shares Issue: The complaint states that under a stock loan agreement with St. James Bank, the pledged Datavault shares were supposed to be held as collateral but were improperly transferred and sold, leading to severe financial losses for the company.
- Market Impact: The complaint alleges that the trading activity involving the pledged shares significantly impacted the market price of Datavault stock, causing substantial financial harm to Scilex, reflecting the company's vulnerability in capital markets.
- Legal Recovery Efforts: Scilex is seeking to recover the pledged shares and compensatory damages exceeding $100 million, demonstrating the company's strong commitment to protecting shareholder interests while revealing challenges in legal compliance.








